Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Jin Zhou, Madhulika Tripathi, Rohit A. Sinha, et al.
Hepatoma Research (2021) Vol. 2021
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Human gut microbiota in health and disease: Unveiling the relationship
Muhammad Afzaal, Farhan Saeed, Yasir Abbas Shah, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 290
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease
Jonathan G. Stine, Michelle T. Long, Kathleen E. Corey, et al.
Hepatology Communications (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 43
Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation
Lulu Gao, Jia-Min Ma, Yanna Fan, et al.
International Journal of Biological Macromolecules (2021) Vol. 183, pp. 1379-1392
Closed Access | Times Cited: 93
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, et al.
Livers (2022) Vol. 2, Iss. 1, pp. 30-76
Open Access | Times Cited: 44
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 27
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeong Jun Song
Nutrients (2023) Vol. 15, Iss. 18, pp. 3970-3970
Open Access | Times Cited: 22
Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis
Ting Wang, Taichi Ishikawa, Minoru Sasaki, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 36
Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
Salvatore Pezzino, Maria Sofia, Gloria Faletra, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1622-1622
Open Access | Times Cited: 31
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis
Ana María Gómez Pérez, P. Ruiz‐Limón, Jordi Salas‐Salvadó, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
С. К. Груздев, I. V. Podoprigora, О. А. Гизингер
Archives of Microbiology (2024) Vol. 206, Iss. 2
Open Access | Times Cited: 5
Deciphering the role of Dietary Modifications and Gut Dysbiosis in Non-Alcoholic Fatty Liver Disease
Meenakshi Vachher, Kamaljeet Kaur, Manisha Mahrotra, et al.
Human Nutrition & Metabolism (2025), pp. 200305-200305
Open Access
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay
Ludovico Abenavoli, L. Giubilei, Anna Caterina Procopio, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5323-5323
Open Access | Times Cited: 24
The identification of metabolites from gut microbiota in NAFLD via network pharmacology
Ki‐Kwang Oh, Haripriya Gupta, Byeong Hyun Min, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Shaping the gut microbiota by bioactive phytochemicals: An emerging approach for the prevention and treatment of human diseases
Surya Sudheer, Prateeksha Gangwar, Zeba Usmani, et al.
Biochimie (2021) Vol. 193, pp. 38-63
Closed Access | Times Cited: 30
Anti-Hyperlipidemia, Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet
Nadiah S. Alzahrani, Ghedeir M. Alshammari, Afaf El-Ansary, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1791-1791
Open Access | Times Cited: 20
A maternal higher-complex carbohydrate diet increases bifidobacteria and alters early life acquisition of the infant microbiome in women with gestational diabetes mellitus
Kameron Y. Sugino, Teri L. Hernandez, Linda A. Barbour, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
The pathogenic oral–gut–liver axis: new understandings and clinical implications
Jin Imai, Sho Kitamoto, Nobuhiko Kamada
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 7, pp. 727-736
Open Access | Times Cited: 26
Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
Stanislav Kotlyarov, Aleksei Bulgakov
Cells (2021) Vol. 10, Iss. 11, pp. 2978-2978
Open Access | Times Cited: 26
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
Shaghayegh Baradaran Ghavami, Hamid Asadzadeh Aghdaei, Dario Sorrentino, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8274-8274
Open Access | Times Cited: 23
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Mohamad Khalil, Agostino Di Ciaula, Laura Mahdi, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2333-2333
Open Access | Times Cited: 3
Associations of altered hepatic gene expression in American lifestyle-induced obesity syndrome diet-fed mice with metabolic changes during NAFLD development and progression
Valeria Iannone, Johnson Lok, Ambrin Farizah Babu, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 115, pp. 109307-109307
Open Access | Times Cited: 7
Tomato Pectin Ameliorated Hepatic Steatosis in High-Fat-Diet Mice by Modulating Gut Microbiota and Bile Acid Metabolism
Pan Wang, Jing Sun, Wenting Zhao, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 24, pp. 13700-13716
Closed Access | Times Cited: 2
Changes in the gut microbiota of rats after exposure to the fungicide Mancozeb
Marina Ferri Pezzini, Pabulo Henrique Rampelotto, Juliana Dall’Agnol, et al.
Toxicology and Applied Pharmacology (2023) Vol. 466, pp. 116480-116480
Closed Access | Times Cited: 5
Plant sterol ester of α-linolenic acid improves NAFLD through modulating gut microbiota and attenuating lipopolysaccharide-induced inflammation via regulating TLR4/NF-κB signaling pathway
Hao Han, Linqi Wang, Tingli Xue, et al.
Journal of Functional Foods (2022) Vol. 94, pp. 105137-105137
Open Access | Times Cited: 8
Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances
Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top